» Articles » PMID: 7936129

Patient Outcomes After Stereotactic Radiosurgery for "operable" Arteriovenous Malformations

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 1994 Jul 1
PMID 7936129
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

To define the outcomes after stereotactic radiosurgery performed for smaller volume arteriovenous malformations (AVMs) that are potentially suitable for surgical removal, we retrospectively reviewed our 4-year experience in 65 patients who declined microsurgery. All 65 patients had Spetzler-Martin Grade I or II AVMs and a minimum follow-up of 24 months (median, 29 mo). Symptomatic improvement after radiosurgery occurred in 52% of patients with seizures and in 63% of patients with headaches. The annual risk of AVM hemorrhage during the latency interval after radiosurgery was 3.7%. Five patients (7.7%) had a subsequent hemorrhage (all within 8 mo of radiosurgery); two died, and three recovered (one after hematoma evacuation and two with conservative management). Forty-seven patients (72%) returned to their previous employment status or activity level within 1 week of radiosurgery (92% within 1 yr). No patient suffered radiation-related complications. Twenty-seven (84%) of 32 patients evaluated by postradiosurgical angiography had complete AVM obliteration. Radiosurgery is an effective and less invasive management strategy for Grade I or II AVM patients who are either medically unsuitable for or unwilling to undergo surgical removal. The risk of AVM hemorrhage during the latency interval until obliteration occurs appears to be no different than the natural history of untreated AVMs. These results (including hemorrhage prevention and symptom amelioration) indicate that the conservative management of small AVMs can rarely be justified.

Citing Articles

Fractal-Based Analysis of Arteriovenous Malformations (AVMs).

Ieva A, Reishofer G Adv Neurobiol. 2024; 36:413-428.

PMID: 38468045 DOI: 10.1007/978-3-031-47606-8_21.


Image-guided robotic radiosurgery for the treatment of arteriovenous malformations.

Loebel F, Pontoriero A, Kluge A, Iati G, Acker G, Kufeld M PLoS One. 2022; 17(9):e0266744.

PMID: 36137082 PMC: 9499208. DOI: 10.1371/journal.pone.0266744.


Occlusion of Animal Model Arteriovenous Malformations Using Vascular Targeting.

Gauden A, McRobb L, Lee V, Subramanian S, Moutrie V, Zhao Z Transl Stroke Res. 2019; 11(4):689-699.

PMID: 31802427 DOI: 10.1007/s12975-019-00759-y.


Endovascular Treatment for Low-Grade (Spetzler-Martin I-II) Brain Arteriovenous Malformations.

Baharvahdat H, Blanc R, Fahed R, Smajda S, Ciccio G, Desilles J AJNR Am J Neuroradiol. 2019; 40(4):668-672.

PMID: 30792251 PMC: 7048507. DOI: 10.3174/ajnr.A5988.


Modern radiosurgical and endovascular classification schemes for brain arteriovenous malformations.

Meybodi A, Lawton M Neurosurg Rev. 2018; 43(1):49-58.

PMID: 29728873 DOI: 10.1007/s10143-018-0983-8.